Challenges in reintroducing tuberculosis medications after hepatotoxicity
- PMID: 20156056
- DOI: 10.1086/650577
Challenges in reintroducing tuberculosis medications after hepatotoxicity
Comment on
-
Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity.Clin Infect Dis. 2010 Mar 15;50(6):833-9. doi: 10.1086/650576. Clin Infect Dis. 2010. PMID: 20156055 Clinical Trial.
Similar articles
-
Hepatotoxicity in the treatment of tuberculosis using moxifloxacin-containing regimens.Int J Tuberc Lung Dis. 2011 Sep;15(9):1275-6. doi: 10.5588/ijtld.11.0352. Int J Tuberc Lung Dis. 2011. PMID: 21943863 No abstract available.
-
Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity.Clin Infect Dis. 2010 Mar 15;50(6):833-9. doi: 10.1086/650576. Clin Infect Dis. 2010. PMID: 20156055 Clinical Trial.
-
[Hepatic function and antitubercular drugs].Clin Ter. 1978 Sep 15;86(5):495-501. Clin Ter. 1978. PMID: 367684 Review. Italian. No abstract available.
-
Antituberculosis drugs and hepatotoxicity.Infect Genet Evol. 2004 Jun;4(2):167-70. doi: 10.1016/j.meegid.2003.01.001. Infect Genet Evol. 2004. PMID: 15157635 No abstract available.
-
[Tuberculosis treatment in adults].Rev Prat. 2012 Apr;62(4):495-501. Rev Prat. 2012. PMID: 22641888 Review. French.
Cited by
-
Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.Expert Rev Gastroenterol Hepatol. 2016;10(4):517-36. doi: 10.1586/17474124.2016.1127756. Epub 2015 Dec 25. Expert Rev Gastroenterol Hepatol. 2016. PMID: 26633044 Free PMC article.
-
Clinical standards for the management of adverse effects during treatment for TB.Int J Tuberc Lung Dis. 2023 Jul 1;27(7):506-519. doi: 10.5588/ijtld.23.0078. Int J Tuberc Lung Dis. 2023. PMID: 37353868 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical